342 related articles for article (PubMed ID: 36059707)
1. Metabolic management of microenvironment acidity in glioblastoma.
Seyfried TN; Arismendi-Morillo G; Zuccoli G; Lee DC; Duraj T; Elsakka AM; Maroon JC; Mukherjee P; Ta L; Shelton L; D'Agostino D; Kiebish M; Chinopoulos C
Front Oncol; 2022; 12():968351. PubMed ID: 36059707
[TBL] [Abstract][Full Text] [Related]
2. Metabolic therapy: a new paradigm for managing malignant brain cancer.
Seyfried TN; Flores R; Poff AM; D'Agostino DP; Mukherjee P
Cancer Lett; 2015 Jan; 356(2 Pt A):289-300. PubMed ID: 25069036
[TBL] [Abstract][Full Text] [Related]
3. Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?
Seyfried TN; Shelton L; Arismendi-Morillo G; Kalamian M; Elsakka A; Maroon J; Mukherjee P
Neurochem Res; 2019 Oct; 44(10):2392-2404. PubMed ID: 31025151
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.
Mukherjee P; Augur ZM; Li M; Hill C; Greenwood B; Domin MA; Kondakci G; Narain NR; Kiebish MA; Bronson RT; Arismendi-Morillo G; Chinopoulos C; Seyfried TN
Commun Biol; 2019; 2():200. PubMed ID: 31149644
[TBL] [Abstract][Full Text] [Related]
5. Ketogenic Metabolic Therapy, Without Chemo or Radiation, for the Long-Term Management of
Seyfried TN; Shivane AG; Kalamian M; Maroon JC; Mukherjee P; Zuccoli G
Front Nutr; 2021; 8():682243. PubMed ID: 34136522
[No Abstract] [Full Text] [Related]
6. Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis.
Chinopoulos C; Seyfried TN
ASN Neuro; 2018; 10():1759091418818261. PubMed ID: 30909720
[TBL] [Abstract][Full Text] [Related]
7. Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer.
Seyfried TN; Mukherjee P; Iyikesici MS; Slocum A; Kalamian M; Spinosa JP; Chinopoulos C
Front Nutr; 2020; 7():21. PubMed ID: 32219096
[TBL] [Abstract][Full Text] [Related]
8. Can the Mitochondrial Metabolic Theory Explain Better the Origin and Management of Cancer than Can the Somatic Mutation Theory?
Seyfried TN; Chinopoulos C
Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564387
[TBL] [Abstract][Full Text] [Related]
9. Press-pulse: a novel therapeutic strategy for the metabolic management of cancer.
Seyfried TN; Yu G; Maroon JC; D'Agostino DP
Nutr Metab (Lond); 2017; 14():19. PubMed ID: 28250801
[TBL] [Abstract][Full Text] [Related]
10. Glucose fluxes in glycolytic and oxidative pathways detected in vivo by deuterium magnetic resonance spectroscopy reflect proliferation in mouse glioblastoma.
Simões RV; Henriques RN; Cardoso BM; Fernandes FF; Carvalho T; Shemesh N
Neuroimage Clin; 2022; 33():102932. PubMed ID: 35026626
[TBL] [Abstract][Full Text] [Related]
11. The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma.
Vallejo FA; Shah SS; de Cordoba N; Walters WM; Prince J; Khatib Z; Komotar RJ; Vanni S; Graham RM
J Neurooncol; 2020 Apr; 147(2):317-326. PubMed ID: 32096068
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Reprogramming of Glioblastoma Cells during HCMV Infection Induces Secretome-Mediated Paracrine Effects in the Microenvironment.
Harrison MAA; Hochreiner EM; Benjamin BP; Lawler SE; Zwezdaryk KJ
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062307
[TBL] [Abstract][Full Text] [Related]
13. Nontoxic Targeting of Energy Metabolism in Preclinical VM-M3 Experimental Glioblastoma.
Augur ZM; Doyle CM; Li M; Mukherjee P; Seyfried TN
Front Nutr; 2018; 5():91. PubMed ID: 30349820
[No Abstract] [Full Text] [Related]
14. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
15. The angiogenic switch leads to a metabolic shift in human glioblastoma.
Talasila KM; Røsland GV; Hagland HR; Eskilsson E; Flønes IH; Fritah S; Azuaje F; Atai N; Harter PN; Mittelbronn M; Andersen M; Joseph JV; Hossain JA; Vallar L; Noorden CJ; Niclou SP; Thorsen F; Tronstad KJ; Tzoulis C; Bjerkvig R; Miletic H
Neuro Oncol; 2017 Mar; 19(3):383-393. PubMed ID: 27591677
[TBL] [Abstract][Full Text] [Related]
16. Neuronal-glial interactions in rats fed a ketogenic diet.
Melø TM; Nehlig A; Sonnewald U
Neurochem Int; 2006; 48(6-7):498-507. PubMed ID: 16542760
[TBL] [Abstract][Full Text] [Related]
17. The role of metabolic therapy in treating glioblastoma multiforme.
Maroon JC; Seyfried TN; Donohue JP; Bost J
Surg Neurol Int; 2015; 6():61. PubMed ID: 25949849
[TBL] [Abstract][Full Text] [Related]
18. High-capacity glycolytic and mitochondrial oxidative metabolisms mediate the growth ability of glioblastoma.
Kim J; Han J; Jang Y; Kim SJ; Lee MJ; Ryu MJ; Kweon GR; Heo JY
Int J Oncol; 2015 Sep; 47(3):1009-16. PubMed ID: 26202438
[TBL] [Abstract][Full Text] [Related]
19. The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer.
Meidenbauer JJ; Mukherjee P; Seyfried TN
Nutr Metab (Lond); 2015; 12():12. PubMed ID: 25798181
[TBL] [Abstract][Full Text] [Related]
20. Mammalian Target of Rapamycin 2 (MTOR2) and C-MYC Modulate Glucosamine-6-Phosphate Synthesis in Glioblastoma (GBM) Cells Through Glutamine: Fructose-6-Phosphate Aminotransferase 1 (GFAT1).
Liu B; Huang ZB; Chen X; See YX; Chen ZK; Yao HK
Cell Mol Neurobiol; 2019 Apr; 39(3):415-434. PubMed ID: 30771196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
